XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Balance at beginning of period at Dec. 31, 2018 $ 394,567     $ 270,447 $ 124,120  
Balance at beginning of period (in shares) at Dec. 31, 2018 [1]     438,642      
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201602Member          
Exercise of common stock options $ 29,874     29,874    
Exercise of common stock options (in shares) [1]     12,641      
Stock-based compensation 82,346     82,346    
Issuance of common stock under employee stock purchase plan 16,746     16,746    
Issuance of common stock under employee stock purchase plan (in shares) [1]     2,870      
Issuance of restricted stock, net of forfeitures and shares withheld for taxes (19,334)     (19,334)    
Issuance of restricted stock, net of forfeitures and shares withheld for taxes (in shares) [1]     603      
Net income 108,318       108,318  
Balance at end of period at Dec. 31, 2019 $ 612,517 $ (388)   380,079 232,438 $ (388)
Balance at end of period (in shares) at Dec. 31, 2019 [1]     454,755      
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member us-gaap:AccountingStandardsUpdate201613Member        
Exercise of common stock options $ 76,146     76,146    
Exercise of common stock options (in shares) [1]     15,448      
Stock-based compensation 114,020     114,020    
Issuance of common stock under employee stock purchase plan 21,671     21,671    
Issuance of common stock under employee stock purchase plan (in shares) [1]     2,685      
Issuance of restricted stock, net of forfeitures and shares withheld for taxes (53,138)     (53,138)    
Issuance of restricted stock, net of forfeitures and shares withheld for taxes (in shares) [1]     513      
Net income 242,317       242,317  
Balance at end of period at Dec. 31, 2020 $ 1,013,145     538,778 474,367  
Balance at end of period (in shares) at Dec. 31, 2020 [1]     473,401      
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201912Member          
Exercise of common stock options $ 61,476     61,476    
Exercise of common stock options (in shares) [1]     7,361      
Stock-based compensation 340,733     340,733    
Issuance of common stock under employee stock purchase plan 29,229     29,229    
Issuance of common stock under employee stock purchase plan (in shares) [1]     1,719      
Issuance of restricted stock, net of forfeitures and shares withheld for taxes (56,855)     (56,855)    
Issuance of restricted stock, net of forfeitures and shares withheld for taxes (in shares) [1]     935      
Issuance of restricted stock related to acquisition 1,816     1,816    
Issuance of common stock related to acquisition (in shares) [1]     25      
Net income 137,762       137,762  
Balance at end of period at Dec. 31, 2021 $ 1,527,306     $ 915,177 $ 612,129  
Balance at end of period (in shares) at Dec. 31, 2021 [1]     483,441      
[1] Refer to Note 9—Capitalization for discussion of the Company’s two classes of common stock.